We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A

204 hedge funds and large institutions have $2.2B invested in Bio-Rad Laboratories Class A in 2014 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 80 increasing their positions, 57 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

691% more call options, than puts

Call options by funds: $1.8M | Put options by funds: $227K

50% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 22

40% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 57

6% more funds holding

Funds holding: 193204 (+11)

1.25% more ownership

Funds ownership: 76.44%77.69% (+1.2%)

4% less capital invested

Capital invested by funds: $2.31B → $2.2B (-$101M)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
204
Holders Change
+11
Holders Change %
+5.7%
% of All Funds
5.86%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
33
Increased
80
Reduced
57
Closed
22
Calls
$1.8M
Puts
$227K
Net Calls
+$1.57M
Net Calls Change
+$1.28M
Name Holding Trade Value Shares
Change
Change in
Stake
SPC
151
Stewart & Patten Company
California
$370K
AIP
152
Ameritas Investment Partners
Nebraska
$367K
WG
153
Winton Group
United Kingdom
$367K +$374K +3,064 New
BA
154
BlackRock Advisors
Delaware
$360K
OA
155
OFI Advisors
Pennsylvania
$353K +$56.7K +464 +19%
Asset Management One
156
Asset Management One
Japan
$353K +$360K +2,948 New
SAM
157
Securian Asset Management
Minnesota
$345K
COPPSERS
158
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$336K
ZIM
159
Zacks Investment Management
Illinois
$324K -$2.2K -18 -0.7%
VFA
160
Virtus Fund Advisers
Connecticut
$304K +$311K +2,543 New
LIM
161
Leavell Investment Management
Alabama
$299K
AL
162
Airain Ltd
Guernsey
$293K +$299K +2,447 New
DTL
163
Dynamic Technology Lab
Singapore
$289K +$295K +2,417 New
CAM
164
Capstone Asset Management
Texas
$287K +$68.4K +560 +30%
WBC
165
Westpac Banking Corp
Australia
$286K +$94.9K +777 +48%
SCM
166
Shelton Capital Management
Colorado
$274K
PP
167
Paloma Partners
Connecticut
$269K +$274K +2,243 New
AG
168
Aperio Group
California
$268K +$20.4K +167 +8%
JG
169
Jefferies Group
New York
$266K +$271K +2,223 New
CG
170
Clinton Group
New York
$263K +$268K +2,197 New
Nomura Holdings
171
Nomura Holdings
Japan
$254K +$259K +2,123 New
VKH
172
Virtu KCG Holdings
New York
$243K +$248K +2,034 New
CONA
173
Capital One National Association
New York
$235K
WAM
174
World Asset Management
Michigan
$226K -$10.3K -84 -4%
OI
175
Oakbrook Investments
Illinois
$225K -$54.9K -450 -19%

BIO Hedge Fund Activity: Q2 2014 in Review

204 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2014, worth a combined $2.2B — down 4.4% from $2.31B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new BIO positions and 22 closed out — a net gain of 11 holders — while 80 added to existing stakes and 57 trimmed.

The largest buyer was Norges Bank, adding an estimated $18.9M. The largest seller was Fidelity Investments, cutting an estimated $24.4M.

  • 204 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2014, up from 193 in Q1 2014.
  • Funds reported $2.2B of Bio-Rad Laboratories Class A stock for Q2 2014, down 4.4% quarter-over-quarter.
  • 33 funds opened new Bio-Rad Laboratories Class A positions in Q2 2014 and 22 closed out, a net change of +11 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q2 2014 was Norges Bank, an estimated $18.9M added.
  • The largest Bio-Rad Laboratories Class A seller in Q2 2014 was Fidelity Investments, an estimated $24.4M sold.

Based on aggregated 13F filings for Q2 2014.